Samalin Investment Counsel’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Buy
705
+1
+0.1% +$371 0.09% 262
2026
Q1
$206K Sell
704
-24
-3% -$7.89K 0.07% 288
2025
Q4
$255K Sell
728
-108
-13% -$36.5K 0.09% 258
2025
Q3
$270K Sell
836
-69
-8% -$21.5K 0.09% 267
2025
Q2
$352K Sell
905
-39
-4% -$15.7K 0.14% 230
2025
Q1
$411K Buy
944
+115
+14% +$46.2K 0.17% 188
2024
Q4
$306K Sell
829
-47
-5% -$19.7K 0.13% 219
2024
Q3
$455K Buy
876
+2
+0.2% +$1.07K 0.2% 172
2024
Q2
$474K Buy
874
+14
+2% +$7.4K 0.22% 149
2024
Q1
$446K Sell
860
-225
-21% -$112K 0.21% 164
2023
Q4
$512K Buy
1,085
+20
+2% +$9.25K 0.26% 125
2023
Q3
$464K Sell
1,065
-12
-1% -$5.44K 0.27% 116
2023
Q2
$479K Buy
1,077
+359
+50% +$166K 0.26% 121
2023
Q1
$330K Buy
718
+4
+0.6% +$1.9K 0.2% 148
2022
Q4
$366K Hold
714
0.23% 130
2022
Q3
$324K Sell
714
-30
-4% -$14.4K 0.24% 130
2022
Q2
$359K Hold
744
0.25% 124
2022
Q1
$365K Buy
744
+191
+35% +$87.3K 0.22% 138
2021
Q4
$257K Buy
+553
New +$233K 0.15% 194
2021
Q3
Sell
-540
Closed -$207K 244
2021
Q2
$207K Buy
+540
New +$206K 0.13% 223
2020
Q1
Sell
-370
Closed -$111K 244
2019
Q4
$111K Buy
+370
New +$102K 0.09% 211

Other funds holding ELV

Samalin Investment Counsel's ELV Position: Q2 2026 in Review

Samalin Investment Counsel increased its Elevance Health (ELV) stake by 0.14% in Q2 2026, buying an estimated $371 and bringing the position to 705 shares worth $273K. The position accounts for 0.09% of the portfolio, ranked #262.

Samalin Investment Counsel first reported a position in ELV in Q4 2019 and has held it in 21 quarters since. The position peaked at $512K in Q4 2023. 565 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Samalin Investment Counsel held 705 shares of Elevance Health worth $273K as of Q2 2026.
  • Samalin Investment Counsel bought 1 Elevance Health share in Q2 2026, an estimated $371.
  • Elevance Health made up 0.09% of Samalin Investment Counsel's portfolio in Q2 2026, its #262 holding.
  • Samalin Investment Counsel first reported a position in Elevance Health in Q4 2019 and has held it in 21 quarters since.
  • Samalin Investment Counsel's Elevance Health position peaked at $512K in Q4 2023.
  • 565 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.